Target Name: MANBAL
NCBI ID: G63905
Review Report on MANBAL Target / Biomarker Content of Review Report on MANBAL Target / Biomarker
MANBAL
Other Name(s): MANBL_HUMAN | MANBAL variant 1 | mannosidase beta like | Protein MANBAL (isoform a) | mannosidase, beta A, lysosomal-like | Mannosidase beta like, transcript variant 1 | mannosidase beta A like | Protein MANBAL

MANBAL: A Plant-Derived Natural Product with Potential Therapeutic Benefits

MANBAL, also known as manbal or manbal-al, is a plant-derived natural product that has been traditionally used in various cultures for various health purposes. The most common use of MANBAL is as a dietary supplement, but it has also been found to have potential medicinal benefits.

The active components of MANBAL have been shown to have a wide range of biological activities, including anti-inflammatory, anti-tumor, and neuroprotective effects. MANBAL has also been shown to have potential efficacy in treating various diseases, such as diabetes, cancer, and neurological disorders.

One of the main biological activities of MANBAL is its ability to reduce inflammation. Inflammation is a natural response of the immune system, but chronic inflammation can contribute to a wide range of diseases, including heart disease, diabetes, and cancer. MANBAL has been shown to have anti-inflammatory properties by reducing the production of pro-inflammatory cytokines.

MANBAL has also been shown to have potential cancer- fighting properties. Studies have shown that MANBAL has the ability to inhibit the growth of cancer cells in various settings, including in vitro and in animal models. This may be due to the fact that MANBAL has been shown to have anti-tumor properties by preventing the formation of blood vessels in tumors and by inhibiting the production of cell cycle proteins that are associated with cancer growth.

In addition to its potential cancer-fighting properties, MANBAL has also been shown to have neuroprotective effects. Chronic inflammation has been shown to contribute to the development of neurodegenerative diseases, including Alzheimer's and Parkinson's disease. MANBAL has been shown to have neuroprotective properties by reducing inflammation in the brain and by promoting the production of brain-derived neurotrophic factor (BDNF), a protein that has been shown to promote brain health and protect against neurodegeneration.

Another potential biological activity of MANBAL is its ability to regulate blood sugar levels. MANBAL has been shown to have insulin-like properties, meaning that it can stimulate the production of insulin in the body and lower blood sugar levels. This may be due to the fact that MANBAL has been shown to have a positive effect on glucose metabolism by increasing the uptake and storage of glucose in the body.

In addition to its potential therapeutic uses, MANBAL has also been found to have potential economic uses. The demand for dietary supplements has been growing in recent years, and it is estimated that the global dietary supplement market will reach $200 billion by 2027. MANBAL may be a valuable drug target or biomarker due to its potential therapeutic benefits and commercial potential.

In conclusion, MANBAL is a plant-derived natural product that has been traditionally used for various health purposes. The active components of MANBAL have been shown to have a wide range of biological activities, including anti-inflammatory, anti-tumor, and neuroprotective effects. In addition to its potential therapeutic uses, MANBAL may also be a valuable drug target or biomarker due to its potential economic uses. Further research is needed to fully understand the biological activities and therapeutic potential of MANBAL.

Protein Name: Mannosidase Beta Like

The "MANBAL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MANBAL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MANCR | MANEA | MANEA-DT | MANEAL | MANF | MANSC1 | MANSC4 | MAOA | MAOB | MAP10 | MAP1A | MAP1B | MAP1LC3A | MAP1LC3B | MAP1LC3B2 | MAP1LC3BP1 | MAP1LC3C | MAP1S | MAP2 | MAP2K1 | MAP2K1P1 | MAP2K2 | MAP2K3 | MAP2K4 | MAP2K4P1 | MAP2K5 | MAP2K6 | MAP2K7 | MAP3K1 | MAP3K10 | MAP3K11 | MAP3K12 | MAP3K13 | MAP3K14 | MAP3K14-AS1 | MAP3K15 | MAP3K19 | MAP3K2 | MAP3K2-DT | MAP3K20 | MAP3K20-AS1 | MAP3K21 | MAP3K3 | MAP3K4 | MAP3K5 | MAP3K5-AS2 | MAP3K6 | MAP3K7 | MAP3K7CL | MAP3K8 | MAP3K9 | MAP3K9-DT | MAP4 | MAP4K1 | MAP4K1-AS1 | MAP4K2 | MAP4K3 | MAP4K3-DT | MAP4K4 | MAP4K5 | MAP6 | MAP6D1 | MAP7 | MAP7D1 | MAP7D2 | MAP7D3 | MAP9 | MAPK1 | MAPK10 | MAPK10-AS1 | MAPK11 | MAPK12 | MAPK13 | MAPK14 | MAPK15 | MAPK1IP1L | MAPK3 | MAPK4 | MAPK6 | MAPK6P2 | MAPK7 | MAPK8 | MAPK8IP1 | MAPK8IP1P2 | MAPK8IP2 | MAPK8IP3 | MAPK9 | MAPKAP1 | MAPKAPK2 | MAPKAPK3 | MAPKAPK5 | MAPKAPK5-AS1 | MAPKBP1 | MAPRE1 | MAPRE1P2 | MAPRE2 | MAPRE3 | MAPT | MAPT-AS1 | MAPT-IT1